Ceftizoxime: clinical evaluation of efficacy and safety in the U.S.A.
D000005:Abdomen; D001170:Arthritis, Infectious / Q000188:drug therapy; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002439:Cefotaxime / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015296:Ceftizoxime; D002986:Clinical Trials as Topic; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D008581:Meningitis / Q000188:drug therapy; D010000:Osteitis / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D014481:United States; D014552:Urinary Tract Infections / Q000188:drug therapy
D015296:Ceftizoxime; D002439:Cefotaxime